InvestorsHub Logo
icon url

alertmeipp

01/04/24 10:13 AM

#2836 RE: Lishur #2835

Just the net cash + 45% royalty alone translates to $20 per share for ENTA.

Its COVID drug is not dead as PFE's still make billions in sale.